Clinical Trial Update: Gemcitabine With or Without CI-994 in Treating Patients With Advanced Non-small Cell Lung Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating gemcitabine with or without CI-994 in advanced non-small cell lung cancer has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CI-994
• Gemzar (gemcitabine)

Snippet

Sponsor: Pfizer | Conditions: Lung Cancer | Phase 3 | Status: COMPLETED